These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12466340)

  • 1. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
    Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
    Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
    Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
    Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
    Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
    Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
    Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
    J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
    Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
    Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
    Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase deficiency, a rare syndrome: case report.
    Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
    J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mutations resulting in estrogen insufficiency in the male.
    Simpson ER
    Mol Cell Endocrinol; 1998 Oct; 145(1-2):55-9. PubMed ID: 9922099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.
    Smith EP; Boyd J; Frank GR; Takahashi H; Cohen RM; Specker B; Williams TC; Lubahn DB; Korach KS
    N Engl J Med; 1994 Oct; 331(16):1056-61. PubMed ID: 8090165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
    Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
    J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.
    Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V
    Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S; Kajantie E; Dunkel L
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I; Goemaere S; Kaufman JM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
    Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
    Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
    Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor.
    MacGillivray MH; Morishima A; Conte F; Grumbach M; Smith EP
    Horm Res; 1998; 49 Suppl 1():2-8. PubMed ID: 9554463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.